Cargando…
Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation
Allogeneic hematopoietic stem cell transplantation (alloSCT) carries the promise of cure for many malignant and non-malignant diseases of the lympho-hematopoietic system. Although outcome has improved considerably since the pioneering Seattle achievements more than 5 decades ago, non-relapse mortali...
Autores principales: | Luft, Thomas, Dreger, Peter, Radujkovic, Aleksandar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273852/ https://www.ncbi.nlm.nih.gov/pubmed/34253879 http://dx.doi.org/10.1038/s41409-021-01390-y |
Ejemplares similares
-
Early bilirubinemia after allogeneic stem cell transplantation—an endothelial complication
por: Dai, Hao, et al.
Publicado: (2021) -
Interleukin-18 and Hematopoietic Recovery after Allogeneic Stem Cell Transplantation
por: Radujkovic, Aleksandar, et al.
Publicado: (2020) -
Pre-transplant testosterone and outcome of men after allogeneic stem cell transplantation
por: Radujkovic, Aleksandar, et al.
Publicado: (2020) -
Interleukin-18 and outcome after allogeneic stem cell transplantation: A retrospective cohort study
por: Radujkovic, Aleksandar, et al.
Publicado: (2019) -
Pre-transplant weight loss predicts inferior outcome after allogeneic stem cell transplantation in patients with myelodysplastic syndrome
por: Radujkovic, Aleksandar, et al.
Publicado: (2015)